A clinical trial to find out if PF-06291874 is safe and tolerated by patients with type 2 diabetes mellitus

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses of PF-06291874 Given as Monotherapy to Adults With Type 2 Diabetes Mellitus

Category & Conditions:
Diabetes and Metabolic Disorders
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
Open Plain Language Summary Result:Click here